About this test
Quantifies CD274 (PD-L1) mRNA expression in tumour tissue by RT-qPCR. Eligibility for immunotherapy is defined by validated PD-L1 immunohistochemistry assays; this test is a supplementary result and does not replace them.
Solid tumours, supplementary marker
Quantifies CD274 (PD-L1) mRNA expression in tumour tissue by RT-qPCR. Eligibility for immunotherapy is defined by validated PD-L1 immunohistochemistry assays; this test is a supplementary result and does not replace them.
As an additional data point for research or case review when requested by the oncologist or pathologist.
Offered on request. Current guidelines give this test a limited role in routine practice; results are reported as genotype or expression data for the ordering clinician to interpret.
Results are reported to the ordering physician and should be interpreted in clinical context.
Contract pricing and turnaround times are provided on request for laboratories and clinics.